CME Group Inc. stock holds near 52-week high after insider sale
Published on 09/16/2026 at 10:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CME Group Inc. stock (ISIN US12572Q1058) closed at USD 280.46 on Nasdaq on September 14, 2026, keeping the share price near its recent 52-week high while reflecting strong profitability in the latest reported quarter.
Insider sale around current price level
According to Investing.com on September 15, 2026, CME Group director Elizabeth Cook sold shares worth USD 140,055, with the transaction executed around USD 280.11 per share.
The same report notes that the sale occurred near the prevailing stock price of USD 280.46, with CME Group maintaining a market capitalization of about USD 100.85 billion as of mid-September 2026, underscoring the company’s status as one of the largest listed derivatives exchanges globally.
Valuation and analyst target context
In a recent discounted cash flow review, GuruFocus calculated an earnings-based intrinsic value of USD 194.04 per share for CME Group and compared it with the prevailing market price of USD 280.46 as of September 15, 2026.
Based on these values, the analysis highlights a margin of safety of minus 44.5 percent, indicating that CME Group stock is trading materially above that intrinsic value estimate at the current level near USD 280.46 per share.
In addition, a recent overview cited in an article on September 15, 2026, points to an average analyst price target of roughly USD 289.75 for CME Group stock, placing the current price of USD 280.46 only about 3.3 percent below that consensus level and suggesting that much of the expected upside is already reflected in the share price.
Profitability supports the premium valuation
Recent quarterly results show CME Group generating robust margins, with the latest reported quarter delivering solid revenue growth compared with the prior-year period, which helps explain why investors have been willing to value the stock at a premium to some intrinsic-value models.
The company’s ability to sustain a return on equity figure in the mid-teens, referred to in recent coverage as averaging around 16.89 percent in recent years, has been a key driver of investor confidence and supports the view that the stock’s valuation near USD 280.46 per share remains underpinned by consistent profitability.
Stock price and trading data
As of the close on September 14, 2026, CME Group Inc. stock finished trading at USD 280.46 on Nasdaq, compared with an earlier quoted intrinsic-value estimate of USD 194.04, and the share price stands close to its recent 52-week high while well above earlier lows in the same period.
CME Group Inc. stock - key data
- Company: CME Group Inc.
- ISIN: US12572Q1058
- Ticker: CME
- Trading venue: Nasdaq
- Price (as of September 14, 2026): 280.46 USD
- Market capitalization: 100.85 billion USD (as of September 15, 2026)
- Sector / Industry: Financials / Diversified Financials
- Index membership: S&P 500
